litlas
ログインアカウント作成

Teresa Macarulla

2005–2025 年に発表

124
論文数
19,340
被引用数
61
h 指数
115
i10 指数

被引用数

Teresa Macarulla の年別被引用数1996 年: 被引用 1 件2001 年: 被引用 1 件2004 年: 被引用 1 件2006 年: 被引用 3 件2007 年: 被引用 2 件2008 年: 被引用 15 件2009 年: 被引用 21 件2010 年: 被引用 37 件2011 年: 被引用 94 件2012 年: 被引用 83 件2013 年: 被引用 94 件2014 年: 被引用 118 件2015 年: 被引用 107 件2016 年: 被引用 115 件2017 年: 被引用 114 件2018 年: 被引用 121 件2019 年: 被引用 465 件2020 年: 被引用 783 件2021 年: 被引用 1,136 件2022 年: 被引用 1,036 件2023 年: 被引用 766 件2024 年: 被引用 1,388 件2025 年: 被引用 789 件2026 年: 被引用 19 件1997〜2000 年は被引用が無いため表示していません2002〜2003 年は被引用が無いため表示していません2005 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,301 件、この内訳の 23.9%中国: 引用元論文 1,173 件、この内訳の 12.2%イタリア: 引用元論文 723 件、この内訳の 7.5%イギリス: 引用元論文 519 件、この内訳の 5.4%スペイン: 引用元論文 504 件、この内訳の 5.2%ドイツ: 引用元論文 497 件、この内訳の 5.2%フランス: 引用元論文 423 件、この内訳の 4.4%日本: 引用元論文 395 件、この内訳の 4.1%カナダ: 引用元論文 252 件、この内訳の 2.6%オランダ: 引用元論文 241 件、この内訳の 2.5%韓国: 引用元論文 227 件、この内訳の 2.4%スイス: 引用元論文 198 件、この内訳の 2.1%
0%23.9%その他 22.5%

機関

分野

  • Medicine64.7%
  • Biochemistry, Genetics and Molecular Biology27.7%
  • Immunology and Microbiology3.8%
  • Materials Science1.1%
  • Engineering0.8%
  • Computer Science0.4%
  • その他1.5%

トピック

  • Pancreatic and Hepatic Oncology Research8%
  • Cancer Genomics and Diagnostics5.3%
  • Colorectal Cancer Treatments and Studies5.1%
  • Cholangiocarcinoma and Gallbladder Cancer Studies4.3%
  • Cancer Immunotherapy and Biomarkers3.7%
  • Cancer Cells and Metastasis2.7%
  • その他70.9%

共著者

全論文

検索で開く
  1. Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer

    著者: Talia Golan, Pascal Hammel, Michele Reni, Eric Van Cutsem, Teresa Macarulla, Michael J. Hall, Joon-Oh Park, Daniel Hochhauser, Dirk Arnold, Do‐Youn Oh, Anke Reinacher‐Schick, Giampaolo Tortora, Hana Algül, Eileen M. O’Reilly, David McGuinness, Karen Cui, Katia Schlienger, Gershon Y. Locker, Hedy L. Kindler - New England Journal of Medicine 2019 被引用: 2,213

  2. Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study

    著者: Ghassan K. Abou‐Alfa, Teresa Macarulla, Milind Javle, Robin Kate Kelley, Sam Joseph Lubner, Jorge Adeva, James M. Cleary, Daniel V.T. Catenacci, Mitesh J. Borad, John Bridgewater, William Proctor Harris, Adrian Murphy, Do‐Youn Oh, Jonathan Whisenant, Maeve A. Lowery, Lipika Goyal, Rachna T. Shroff, Anthony B. El-Khoueiry, Bin Fan, Bin Wu, Christina X. Chamberlain, Liewen Jiang, Camelia Gliser, Shuchi S. Pandya, Juan W. Valle, Andrew X. Zhu - The Lancet Oncology 2020 被引用: 1,075

  3. BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial

    著者: Bruno Bockorny, Valerya Semenisty, Teresa Macarulla, Erkut Borazanci, Brian M. Wolpin, Salomon M. Stemmer, Talia Golan, Ravit Geva, Mitesh J. Borad, Katrina S. Pedersen, Joon Oh Park, Robert A. Ramirez, David Gutiérrez Abad, Jaime Feliú, Andrés Muñoz, Mariano Ponz‐Sarvisé, Amnon Peled, Tzipora M Lustig, Osnat Bohana‐Kashtan, Stephen M. Shaw, Ella Sorani, Marya Chaney, Shaul Kadosh, Abi Vainstein Haras, Daniel D. Von Hoff, Manuel Hidalgo - Nature Medicine 2020 被引用: 533

  4. NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial

    著者: Zev A. Wainberg, Davide Melisi, Teresa Macarulla, Roberto Pazo-Cid, Sreenivasa R Chandana, Christelle de la Fouchardière, Andrew Dean, Igor Kišš, Woo Jin Lee, Thorsten Oliver Goetze, Eric Van Cutsem, Andrew Scott Paulson, Tanios Bekaii‐Saab, Shubham Pant, Richard Hubner, Zhimin Xiao, Huanyu Chen, Fawzi Benzaghou, Eileen M. O’Reilly - The Lancet 2023 被引用: 439

  5. Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation

    著者: Andrew X. Zhu, Teresa Macarulla, Milind Javle, Robin Kate Kelley, Sam Joseph Lubner, Jorge Adeva, James M. Cleary, Daniel V.T. Catenacci, Mitesh J. Borad, John Bridgewater, William Proctor Harris, Adrian Murphy, Do‐Youn Oh, Jonathan Whisenant, Maeve A. Lowery, Lipika Goyal, Rachna T. Shroff, Anthony B. El-Khoueiry, Christina X. Chamberlain, Elia Aguado-Fraile, Sung Choe, Bin Wu, Hua Liu, Camelia Gliser, Shuchi S. Pandya, Juan W. Valle, Ghassan K. Abou‐Alfa - JAMA Oncology 2021 被引用: 473

  6. Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma

    著者: Eric Van Cutsem, Margaret A. Tempero, Darren Sigal, Do‐Youn Oh, Nicola Fazio, Teresa Macarulla, Erika Hitre, Pascal Hammel, Andrew Hendifar, Susan E. Bates, Chung‐Pin Li, Sunil R. Hingorani, Christelle de la Fouchardière, Anup Kasi, Volker Heinemann, Anthony Maraveyas, Nathan Bahary, Laura Layos, Vaibhav Sahai, Lei Zheng, Jill Lacy, Joon Oh Park, Fabienne Portales, Paul E. Oberstein, Wilson Wu, Dimitrios Chondros, Andrea J. Bullock, on behalf of the HALO 109-301 Investigators - Journal of Clinical Oncology 2020 被引用: 446

  7. Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study

    著者: Milind Javle, Sameek Roychowdhury, Robin Kate Kelley, Saeed Sadeghi, Teresa Macarulla, Karl Heinz Weiss, Dirk‐Thomas Waldschmidt, Lipika Goyal, Ivan Borbath, Anthony B. El-Khoueiry, Mitesh J. Borad, Wei Peng Yong, Philip A. Philip, Michael Bitzer, S. Tanasanvimon, Li Ai, Amit Pande, Harris S. Soifer, Stacie Peacock Shepherd, Susan Moran, Andrew X. Zhu, Tanios Bekaii‐Saab, Ghassan K. Abou‐Alfa - ˜The œLancet. Gastroenterology & hepatology 2021 被引用: 425

  8. Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

    著者: Andrea Wang‐Gillam, Chung‐Pin Li, G. Bodoky, Andrew Dean, Yan‐Shen Shan, Gayle Jameson, Teresa Macarulla, Kyung-Hun Lee, David Cunningham, J.F. Blanc, Richard Hubner, Chang‐Fang Chiu, Gilberto Schwartsmann, Jens T. Siveke, Fadi Braiteh, Victor Moyo, Bruce Belanger, Navreet Dhindsa, Eliel Bayever, Daniel D. Von Hoff, Li‐Tzong Chen, Clarence S. Adoo, T Anderson, Jamil Asselah, Alan A. Azambuja, Carolyn Bampton, Carlos H. Barrios, Tanios Bekaii‐Saab, Bohuslav Melichar, David Chang, Jen‐Shi Chen, Yeu‐Chin Chen, Hye Jin Choi, Ik Joo Chung, Vincent Chung, Tibor Csőszi, Antonio Cubillo, Linda C. DeMarco, Maike de Wit, Tomislav Dragovich, W. Jeff Edenfield, Luis Fein, Fábio Franke, Martin Fuchs, Vega Gonzales-Cruz, Alberto Gozza, Rivera Herrero Fernando, Rosario Vincenzo Iaffaioli, Jitka Jakesova, Zsuzsanna Kahán, Misagh Karimi, Jun Suk Kim, Ernesto Korbenfeld, István Láng, Fa-Chyi Lee, Kuan‐Der Lee, Lara Lipton, Wen Wee, László Mangel, Raul Mena, Daniel H. Palmer, Shubham Pant, Joon Oh Park, Paolo Piacentini, Uwe Pelzer, Javier Gállego, Cooray Prasad, Kun‐Ming Rau, Jean‐Luc Raoul, Donald Richards, Paul J. Ross, Luís Alberto Schlittler, Martin Šmakal, V. Stahalova, Cora N. Sternberg, Thomas Seufferlein, Niall C. Tebbutt, J. Vinholes, Raymond Wadlow, Milkos Wenczl, Mark Wong - The Lancet 2015 被引用: 1,200

  9. Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study

    著者: James J. Harding, Jia Fan, Do‐Youn Oh, Hye Jin Choi, Jin Won Kim, Heung-Moon Chang, Lequn Bao, Hui‐Chuan Sun, Teresa Macarulla, Feng Xie, Jean‐Philippe Metges, Jieer Ying, John Bridgewater, Myung Ah Lee, Mohamedtaki Abdulaziz Tejani, Emerson Y. Chen, Dong Uk Kim, Harpreet Wasan, Michel Ducreux, Yuanyuan Bao, Lisa Boyken, Jiafang Ma, Phillip M. Garfin, Shubham Pant, Ghassan K. Abou‐Alfa, J. Adeva Alfonso, Massimo Aglietta, Ari David Baron, Muhammad Shaalan Beg, Paula Carrasco Aguirre, Eric X. Chen, Ying Cheng, Antonio Cubillo Gracián, Laëtitia Dahan, Filippo de Braud, Elisabetta Fenocchio, Olumide Gbolohon, Roopinder Gillmore, Marine Jary, Milind Javle, Yixing Jiang, Jung Hun Kang, Gentry George King, Madappa N. Kundranda, Laura Layos, Daneng Li, Tingbo Liang, Sara Lonardi, Omkar Marathe, Sebastián Mondaca, Andrés J. Muñoz Martín, Joon Oh Park, Roberto Pazo-Cid, Paula Ribera Fernandez, Lorenza Rimassa, Rosa Alonso, Saeed Sadeghi, Aaron J. Scott, Benjamin Tan, David Tougeron, Qiang Yan, Xiaoyu Yin, Haitao Zhao - The Lancet Oncology 2023 被引用: 247

  10. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

    著者: Wendy De Roock, Bart Claes, David Bernasconi, Jef De Schutter, Bart Biesmans, George Fountzilas, Konstantine T. Kalogeras, Vassiliki Kotoula, Demetris Papamichael, Pierre Laurent‐Puig, Frédérique Penault–Llorca, Philippe Rougier, Bruno Vincenzi, Daniele Santini, Giuseppe Tonini, Federico Cappuzzo, Milo Frattini, Francesca Molinari, Piercarlo Saletti, Sara De Dosso, Miriam Martini, Alberto Bardelli, Salvatore Siena, Andrea Sartore‐Bianchi, Josep Tabernero, Teresa Macarulla, Frédéric FIORE, Alice Gangloff, Fortunato Ciardiello, Per Pfeiffer, Camilla Qvortrup, Tine Plato Hansen, Eric Van Cutsem, Hubert Piessevaux, Diether Lambrechts, Mauro Delorenzi, Sabine Tejpar - The Lancet Oncology 2010 被引用: 2,143

  11. Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

    著者: Eric Van Cutsem, Josep Tabernero, Radek Lakomý, Hans Prenen, Jana Prausová, Teresa Macarulla, Paul Ruff, Guy A. Van Hazel, Vladimir Moiseyenko, David Ferry, Joe McKendrick, Jonathan Polikoff, Alexia Tellier, R Castan, Carmen J. Allegra - Journal of Clinical Oncology 2012 被引用: 1,383

  12. Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer

    著者: Davide Melisi, Do‐Youn Oh, Antoine Hollebecque, Emiliano Calvo, Anna M. Varghese, Erkut Borazanci, Teresa Macarulla, Valeria Merz, Camilla Zecchetto, Yumin Zhao, Ivelina Gueorguieva, Michael Man, Leena Gandhi, Shawn T. Estrem, Karim A. Benhadji, Mark C. Lanasa, Emin Avşar, Susan C. Guba, Rocio García‐Carbonero - Journal for ImmunoTherapy of Cancer 2021 被引用: 196

  13. Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma

    著者: Milind Javle, Maeve A. Lowery, Rachna T. Shroff, Karl Heinz Weiss, Christoph Springfeld, Mitesh J. Borad, Ramesh K. Ramanathan, Lipika Goyal, Saeed Sadeghi, Teresa Macarulla, Anthony B. El-Khoueiry, Robin Kate Kelley, Ivan Borbath, Su Pin Choo, Do‐Youn Oh, Philip A. Philip, Li‐Tzong Chen, Thanyanan Reungwetwattana, Eric Van Cutsem, Kun‐Huei Yeh, Kristen K. Ciombor, Richard S. Finn, Anuradha Patel, Suman Sen, Dale Porter, Randi Isaacs, Andrew X. Zhu, Ghassan K. Abou‐Alfa, Tanios Bekaii‐Saab - Journal of Clinical Oncology 2017 被引用: 715

  14. Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer

    著者: Hedy L. Kindler, Pascal Hammel, Michele Reni, Eric Van Cutsem, Teresa Macarulla, Michael J. Hall, Joon Oh Park, Daniel Hochhauser, Dirk Arnold, Do‐Youn Oh, Anke Reinacher‐Schick, Giampaolo Tortora, Hana Algül, Eileen M. O’Reilly, Sonal Bordia, David McGuinness, Karen Cui, Gershon Y. Locker, Talia Golan - Journal of Clinical Oncology 2022 被引用: 225

  15. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022

    著者: Michel Ducreux, Ghassan K. Abou‐Alfa, Tanios Bekaii‐Saab, Jordan Berlin, Andrés Cervantes, Thierry de Baère, Charis Eng, Peter R. Galle, Sharlene Gill, Thomas Gruenberger, Karin Haustermans, Ángela Lamarca, Pierre Laurent‐Puig, Josep M. Llovet, F. Lordick, Teresa Macarulla, Deborah Mukherji, Kei Muro, Radka Obermannová, Juan Manuel O’Connor, Eileen M. O’Reilly, Pia Österlund, P. A. Philip, G. Prager, Erika Ruíz‐García, Bruno Sangro, Thomas Seufferlein, Josep Tabernero, Chris Verslype, Harpreet Wasan, Eric Van Cutsem - ESMO Open 2023 被引用: 161

  16. Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer

    著者: Davide Melisi, Rocio García‐Carbonero, Teresa Macarulla, Denis Pezet, G. Deplanque, Martin Fuchs, Jörg Trojan, Helmut Oettle, Mark Kozloff, Ann Cleverly, Claire Smith, Shawn T. Estrem, Ivelina Gueorguieva, Michael Lahn, Al Blunt, Karim A. Benhadji, Josep Tabernero - British Journal of Cancer 2018 被引用: 274

  17. First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma

    著者: Richard D. Kim, Debashis Sarker, Tim Meyer, Thomas Yau, Teresa Macarulla, Joong‐Won Park, Su Pin Choo, Antoine Hollebecque, Max W. Sung, Ho-Yeong Lim, Vincenzo Mazzaferro, Joerg Trojan, Andrew X. Zhu, Jung‐Hwan Yoon, Sunil Sharma, Zhong-Zhe Lin, Stephen L. Chan, Sandrine Faivre, Lynn G. Feun, Chia-Jui Yen, Jean‐François Dufour, Daniel H. Palmer, Josep M. Llovet, Melissa Manoogian, Meera Tugnait, Nicolas Stransky, Margit Hagel, Nancy E. Kohl, Christoph Lengauer, Cori Ann Sherwin, Oleg Schmidt‐Kittler, Klaus P. Hoeflich, Hongliang Shi, Beni B. Wolf, Yoon‐Koo Kang - Cancer Discovery 2019 被引用: 250

  18. Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors

    著者: Rocio García‐Carbonero, Miriam Bazán‐Peregrino, Marta Gil-Martín, Rafael Álvarez, Teresa Macarulla, María Carmen Riesco Martínez, Helena Verdaguer, Carmen Guillén‐Ponce, Martí Farrera-Sal, Rafael Moreno, Ana Mato-Berciano, María Victoria Maliandi, Silvia Torres-Manjon, Marcel Costa-García, Natalia del Pozo, Jaime Martínez de Villarreal, Francisco X. Real, Noemí Vidal, Gabriel Capellá, Ramón Alemany, E. Blasi, C. Blasco, Manel Cascalló, Ramón Salazar - Journal for ImmunoTherapy of Cancer 2022 被引用: 85

  19. Efficacy and safety of zenocutuzumab, a HER2 x HER3 bispecific antibody, across advanced NRG1 fusion (NRG1+) cancers.

    著者: Alison M. Schram, Kōichi Goto, Dong‐Wan Kim, Patricia Martín-Romano, Sai‐Hong Ignatius Ou, Grainne M. O’Kane, Eileen M. O’Reilly, Kumiko Umemoto, M. Duruisseaux, Cindy Neuzillet, Frans L. Opdam, Jordi Rodon Ahnert, Misako Nagasaka, Benjamin A. Weinberg, Teresa Macarulla, Andrew K. Joe, Jim Ford, Viktoriya Stalbovskaya, Ernesto Wasserman, Alexander Drilon - Journal of Clinical Oncology 2022 被引用: 66

  20. Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 Trial

    著者: Bruno Bockorny, Teresa Macarulla, Valerya Semenisty, Erkut Borazanci, Jaime Feliú, Mariano Ponz‐Sarvisé, David Gutiérrez Abad, Paul E. Oberstein, Angela Alistar, Andrés Muñoz, Ravit Geva, Carmen Guillén‐Ponce, Mercedes Salgado Fernández, Amnon Peled, Marya Chaney, Irit Gliko-Kabir, Liron Shemesh-Darvish, Debby Ickowicz, Ella Sorani, Shaul Kadosh, Abi Vainstein‐Haras, Manuel Hidalgo - Clinical Cancer Research 2021 被引用: 88

  21. FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements

    著者: Tanios S Bekaii-Saab, Juan W. Valle, Eric Van Cutsem, Lorenza Rimassa, Junji Furuse, Tatsuya Ioka, Davide Melisi, Teresa Macarulla, John Bridgewater, Harpreet Wasan, Mitesh J. Borad, Ghassan K. Abou‐Alfa, Ping Jiang, Christine Lihou, Hui‐Ling Zhen, Ekaterine Asatiani, Luis Féliz, Arndt Vogel - Future Oncology 2020 被引用: 165

  22. Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform

    著者: Andrew H. Ko, Kyu‐pyo Kim, Jens T. Siveke, Charles D. Lopez, Jill Lacy, Eileen M. O’Reilly, Teresa Macarulla, Gulam A. Manji, Jeeyun Lee, Jaffer A. Ajani, María Maqueda, Sun Young Rha, Janet Lau, N. Al-Sakaff, Simon Allen, Danny Lu, Colby S. Shemesh, Xinxin Gan, Edward Cha, Do‐Youn Oh - The Oncologist 2023 被引用: 56

  23. mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer

    著者: Amaia Zabala‐Letona, Amaia Arruabarrena-Aristorena, Natalia Martín-Martín, Sonia Fernández‐Ruiz, James D. Sutherland, Michelle Clasquin, Julen Tomás‐Cortázar, José Jimenez, Ines Torres, Phong Quang, Pilar Ximénez‐Embún, Ružica Bago, Aitziber Ugalde‐Olano, Ana Loizaga‐Iriarte, Isabel Lacasa-Viscasillas, Miguel Unda, Verónica Torrano, Diana Cabrera, Sebastiaan van Liempd, Ylenia Cendón, Elena Castro, Stuart Murray, Ajinkya Revandkar, Andrea Alimonti, Yinan Zhang, Amelia Barnett, Gina Lein, David Pirman, Ana R. Cortázar, Leire Arreal, Ludmila Prudkin, Ianire Astobiza, Lorea Valcárcel-Jiménez, Patricia Zúñiga-García, Itziar Fernández-Domínguez, Marco Piva, Alfredo Caro‐Maldonado, Pilar Sánchez‐Mosquera, Mireia Castillo-Martín, Violeta Serra, Naiara Beraza, Antonio Gentilella, George Thomas, Mikel Azkargorta, Félix Elortza, Rosa Farrás, David Olmos, Alejo Efeyan, Juan Anguíta, Javier Muñoz, Juan Manuel Falcón‐Pérez, Rosa Barrio, Teresa Macarulla, José M. Mato, Maria Luz Martínez‐Chantar, Carlos Cordon‐Cardo, Ana M. Aransay, Kevin M. Marks, José Baselga, Josep Tabernero, Paolo Nucíforo, Brendan D. Manning, Katya Marjon, Arkaitz Carracedo - Nature 2017 被引用: 217

  24. Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification

    著者: Benedetta Pellegrino, Andrea Herencia-Ropero, Alba Llop‐Guevara, Flaminia Pedretti, Alejandro Moles‐Fernández, Cristina Viaplana, Guillermo Villacampa, Marta Guzmán, Olga Rodríguez, Judit Grueso, José Jimenez, Enrique J. Arenas, Andrea Degasperi, João M.L. Dias, Josep V. Forment, Mark J. O’Connor, Olivier Déas, Stefano Cairo, Yinghui Zhou, Antonino Musolino, Carlos Caldas, Serena Nik‐Zainal, Robert B. Clarke, Paolo Nucíforo, Orland Dı́ez, Xavier Serres, Vicente Peg, Martín Espinosa-Bravo, Teresa Macarulla, Ana Oaknin, Joaquı́n Mateo, Joaquı́n Arribas, Rodrigo Dienstmann, Meritxell Bellet, Mafalda Oliveira, Cristina Saura, Sara Gutiérrez‐Enríquez, Judith Balmañà, Violeta Serra - Cancer Research 2022 被引用: 97